We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Third-Party Shortages Plan Threatened by FTC’s Silence
GPhA Third-Party Shortages Plan Threatened by FTC’s Silence
May 22, 2012
The FTC may not issue the advisory opinion GPhA is waiting for before launching its third-party drug shortage program, possibly derailing the initiative.